We describe eight cases of primary cerebral lymphoma seen in Manitoba from 1980 to 1985.
Primary lymphoma of the CNS constitutes 0.85 to 1.5% of primary brain tumors.
1 ' 2 They are diagnosed more often than before, partly due to improved diagnostic procedures. Some suspect an increase in incidence related to the increased use of radiotherapy and immunosuppressants. 2 Association with renal transplantation, 3 adult immunodeficiency syndrome, 4 systemic lupus erythematosis, 5 Sjogren's syndrome, 6 rheumatoid arthritis, 7 and immunoglobulin A deficiency 8 has been reported. This suggests a relationship to chronic antigenic stimulation. 9 Louie l0 suggested the tendency for occurrence in immunosuppressed hosts may indicate a failure of B lymphocyte regulation by T lymphocytes resulting in neoplastic proliferation of these cells. Most primary CNS lymphomas, however, arise sporadically in patients who have not received immunosuppression and they recapitulate the spectrum of lymphomas arising outside of the CNS."
These tumors were once known by a variety of namesnotably microglioma and reticulum cell sarcoma. More recently ultrastructural and immunologic studies have shown that they are derived from B lymphocytes, 1213 and therefore, should be classified like other malignant lymphomas.
The purpose of this report is to describe eight cases of CNS lymphoma seen in Manitoba and to review the literature. Clinical presentation, radiologic, and histologic features and treatment are discussed.
THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES MATERIAL AND METHODS
Review of hospital records revealed eight cases of primary lymphoma of the CNS presenting to Manitoba's two teaching hospitals (referral population 1,200,000) between January 1980 and December 1984. The charts of these cases were reviewed. Approximately 550 other primary brain tumors presented during this time span.
RESULTS AND DISCUSSION Our eight cases are described in Table 1 . The staging process included hematologic workup (including bone marrow aspiration and biopsy), SMA-12, chest x-ray, and radionucleotide liver and spleen scan. In addition, cases 4,5,7, and 8 had normal abdominal CT scans. Cases 1 and 6 had negative lymphangiograms; cases 3 and 4 had normal intravenous pyelograms. All eight cases were diagnosed pre-mortem by surgical procedures outlined in Table 1 . Five cases are still alive. In two of the deaths, autopsy confirmed Stage I disease. No autopsy was performed in the other death. Data from our cases are combined with the series reported in the literature and presented in Table 2 . CSF findings are included in Table 4 .
Clinical Presentation
These tumors occur from infancy to old age with a peak occurring in the first decade and from the fourth to the seventh decade.
14 The average age in 352 cases reviewed was 52. Male to female ratio was 1.9:1.0.
The most common presenting symptoms and signs were nonspecific and nonlocalizing (>80%). They included headache, nausea and vomiting, possibly implicating raised intracranial pressure (56%). Confusion, memory loss, and personality change also occurred (32%). Focal neurologic symptoms and signs were seen in 42%. Seizures occurred in 9%.
The average duration of symptoms prior to diagnosis was 2.8 months. Our Case 3 is of interest as it suggests the possibility of a primary cerebral lymphoma presenting with seizures 12 years prior to diagnosis, the longest duration reported in the literature. 
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Location Fifty-five percent of tumors occurred in the cerebral white matter, often within or close to the corpus callosum. Some had a butterfly appearance as seen with some glial tumors. Seventeen percent occurred in deep structures (basal ganglia, thalamus, hypothalamus, periventricular white matter). Eleven percent were in the posterior fossa. One percent involved the spinal cord. They were distinctly uncommon superficially, but have rarely been reported to be localised to the leptomeninges. 15 Multiple tumors occurred in 16% of cases.
Radiologic Characteristics
This topic has been reviewed by many authors. 916 " 22 Skull films 23 and radionucleotide brain scans 18 were abnormal in many cases but did not provide information to help identify the tumor type.
The CT scan characteristics of 29 primary cerebral lymphomas have been described 21 using CT scanning without contrast infusion. Twenty-one tumors were dense, five were isodense, two hypodense, and one had variable density in relation to surrounding normal brain tissue. Following contrast infusion, the majority (70%) showed dense homogeneous enhancement. Ten percent showed no enhancement and 20% irregular enhancement. Tallroth 19 also described dense enhancement in the majority of his cases.
Thomas 22 separated his cases into two groups on the basis of the CT scan characteristics. Deep lesions tended to be well demarcated with little mass effect or surrounding edema, and showed marked homogeneous enhancement. More superficial lesions tended to be poorly demarcated. They had variable density with significant surrounding edema and tended to enhance irregularly. Our results supported this observation.
Ninety-one percent of angiograms performed were abnormal (Table 3) . Sixty-three percent showed a mass lesion without increased vascularity. Tumor blush was seen in 28%.
Neither the angiographic nor CT scan appearance is diagnostic of primary cerebral lymphoma. The radiologic picture may suggest glioma, meningioma, or metastatic carcinoma. However, a densely enhancing lesion on CT scan which is avascular on an angiogram should raise suspicion. Multiple lesions with similar characteristics, especially if deeply situated, should also suggest primary cerebral lymphoma 19 .
Cerebrospinal Fluid (CSF) Abnormalities
Eighty-one percent of reported spinal fluid examinations were abnormal with increased protein in 100% of those (Table  4 ). An increased cell count, most frequently mononuclear, was seen in 42%. The accuracy of CSF cytologic diagnosis ranges from 4% to 43.5%. 24 Jellinger 24 suggests that immunologic studies on CSF might be of value. Analysis of CSF protein may show increased levels of immunoglobulins. More studies are needed to determine if such abnormalities would assist in making tumor-specific diagnosis. Unfortunately, as seen in Table 4 , only two of our cases had lumbar punctures. Both were abnormal with positive cytology in one. Immunologic studies were not done. Pathologic Characteristics At the time of surgery these tumors are most often found to be soft greyish-pink masses 16 which can extend to involve meningeal and ependymal surfaces. In two of our cases, the texture was firm, rubbery and lobulated, resembling a meningioma.
Our cases were classified using the Rappaport Classification. 25 The majority of reported cases are lymphocytic or histiocytic ( Table 2) . Six of our eight cases were histiocytic, one was a poorly differentiated lymphocytic, and the other a well differentiated lymphocytic lymphoma (Table 2) . It is now generally accepted that the great majority of these neoplasms are B-cell derived. Cytologic and immunologic analyses allows identification of B-cell subtypes predominant within a tumor. 26 There is, to date, no good evidence that this subclassification is of prognostic significance. As well, this information is not currently used in selecting treatment. The use of monoclonal antibodies on paraffin-embedded tissue can help distinguish lymphomas from other small cell tumors. This latter method does not help differentiate from other inflammatory disorders, but is particularly helpful if biopsy material is limited. 27 
PROGNOSIS AND TREATMENT
The overall prognosis of primary malignant CNS lymphoma is worse than extranodal lymphoma occurring elsewhere. 28 Helle" concluded that a primary CNS lymphoma of diffuse mixed histology or one arising infratentorially is associated with a worse prognosis.
It is generally agreed 114,29 that cranial radiation significantly improves survival. The survival statistics of 68 patients were discussed in the review by Jellinger 1 and the results were representative of those found elsewhere. The mean survival was two months in those receiving no therapy, one month in those receiving surgery alone, and 16 months in patients treated with surgery and cranial radiation. Mean survival for as long as 45 months has been reported in the latter treatment group. 14 Surgery is suggested if a well localised lesion can be safely removed. 30 Overzealous surgery may increase the deficit without improving the long term course. Radiotherapy is an essential complement to any surgical therapy.
The exact dose and field of radiation is debated. Sagerman 23 reported a high percentage of recurrence with total doses below 3500 rads. Littman 30 concluded that a total dose between 4500 and 5500 rads was the treatment of choice. More recently Mendenhall 9 has recommended 4000 to 4500 rads of whole brain radiation with an additional 1500 to 2000 rads to a reduced field around the primary. There is concern however that this "boost" to the tumor may increase the risk of radiation induced encephalopathy. 31 Littman 30 suggested spinal axis radiation be given in those cases with positive CSF cytology. Rampen 31 and Mendenhall 9 recommended spinal axis radiation in all cases, the recommended dosage being 3000 to 3500 rads. All patients should have ophthalmologic examination to rule out lymphomatous vitreous involvement. 9 This association is not uncommon and nongranulomatous uveitis has been reported as a presenting feature by several authors. 32, 33, 34 If positive, orbital radiation should be given.
No large study of chemotherapy for these tumors has been done. Drugs effective for non-CNS lymphoma (bleomycin, cyclophosphamide, adriamycin, vincristine) have poor bloodbrain-barrier penetration. 9 Radiosensitizers should be of benefit but tend to have little effect on lymphomas. 9 Several case reports have suggested some benefit from multiple drug therapy. 9 ' 30, 35 Our case 6 remains alive two years post-treatment with the cyclophosphamide, methotrexate, vincristine, prednisone regime. Amadori 36 described eight patients with active CNS leukemia and lymphoma whom he treated with a combination of high dose cytosine arabinoside and asparaginase. The former drug has good CNS penetration and the latter is synergistic with it. He suggested the therapy was well tolerated and highly effective in terms of CNS tumor regression. Although none of his cases were primary to the CNS, this therapy might be considered for primary cerebral lymphoma.
Intrathecal methotrexate has been used with some success. 37 However, there is a risk of necrotizing leukoencephalopathy when this drug is combined with cranial radiation. 38 Dexamethasone as a chemotherapeutic agent for CNS lymphoma has received little attention. We have noted dramatic improvement in our case 4 ( Table 2 ). This 57 year old male presented with mild right hemiparesis. CT scan showed enhancing lesions in the left frontal and parietal lobes, and in the splenium of the corpus callosum (Figure la) . Clinical symptoms and signs resolved in two weeks with dexamethasone, 16 milligrams orally per day. Serial CT scans showed marked resolution of the lesions (Figure lb) . Dexamethasone was then tapered and stopped over the next six months. No other treatment was given and the patient was asymptomatic for the next year. Symptoms then recurred at which time a repeat CT scan showed recurrent tumor (Figure lc) . Needle biopsy showed histiocytic lymphoma. Five thousand rads of whole brain radiation and dexamethasone provided partial palliation but death occurred eight months later. Cases with a similar marked response to corticosteroids have been described in the literature. 40 ' 45 
CONCLUSION
Primary lymphoma of the CNS remains an uncommon disease. The keys to diagnosis are a high index of suspicion and pathologic confirmation. Treatment modalities beyond radiotherapy require controlled studies before a specific regime can be universally recommended.
